|
Maternal Nutritional Physiological Phenomena
|
G07.203.650.566 |
|
|
ATP Binding Cassette Transporter, Subfamily B, Member 2
|
D12.776.157.530.450.074.500.500.250.250 |
|
|
LDL-Receptor Related Protein-Associated Protein
|
D026563 |
[A membrane protein found in the rough endoplasm reticulum (ENDOPLASMIC RETICULUM, ROUGH) that binds to LDL-RECEPTOR RELATED PROTEINS. It may function to prevent ligand binding of receptors during protein processing events within endosomal compartments.
] |
|
Solid-Phase Synthesis Techniques
|
J01.897.836.249.500 |
|
|
alpha-Defensins
|
D12.776.543.695.054.200.050 |
|
|
Defensins
|
D12.776.543.695.054.200 |
|
|
Interleukin-21 Receptor alpha Subunit
|
D12.776.543.750.705.852.420.900.450 |
|
|
Receptors, Interleukin-21
|
D12.776.543.750.705.852.420.900 |
|
|
Visible Human Projects
|
H01.158.100.185.905 |
|
|
Anatomy, Cross-Sectional
|
H01.158.100.185 |
|
|
Oncogene Proteins v-mos
|
D12.776.964.700.750.900 |
|
|
Trimethoprim, Sulfamethoxazole Drug Combination
|
D02.065.884.725.867.500 |
|
|
Electron Probe Microanalysis
|
E05.196.867.800.360 |
|
|
Spectrometry, X-Ray Emission
|
E05.196.867.800 |
|
|
Severe Dengue
|
C01.925.782.417.214.200 |
|
|
Dengue
|
C01.925.782.417.214 |
|
|
Teprotide
|
D12.644.456.810 |
|
|
Antibodies, Viral
|
D12.776.124.790.651.114.254 |
|
|
Soft Tissue Infections
|
C01.820 |
|
|
Receptor, Fibroblast Growth Factor, Type 5
|
D051500 |
[The most divergent of the known fibroblast growth factor receptors. It does not contain an intracellular TYROSINE KINASE domain and has been shown to interact with FIBROBLAST GROWTH FACTOR 2. Fibroblast growth factor receptor 5 is found primarily in skeletal tissue.
] |
